Nathan Perlis

1.6k total citations
83 papers, 952 citations indexed

About

Nathan Perlis is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nathan Perlis has authored 83 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nathan Perlis's work include Prostate Cancer Diagnosis and Treatment (47 papers), Prostate Cancer Treatment and Research (41 papers) and Urologic and reproductive health conditions (15 papers). Nathan Perlis is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (47 papers), Prostate Cancer Treatment and Research (41 papers) and Urologic and reproductive health conditions (15 papers). Nathan Perlis collaborates with scholars based in Canada, United States and United Kingdom. Nathan Perlis's co-authors include Antonio Finelli, Alexandre R. Zlotta, Neil Fleshner, Girish S. Kulkarni, Sangeet Ghai, Theodorus van der Kwast, Joseph Beyene, Masoom A. Haider, Robert J. Hamilton and Ants Toi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Stroke.

In The Last Decade

Nathan Perlis

78 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Perlis Canada 18 563 296 189 146 138 83 952
Scott Leslie Australia 17 577 1.0× 370 1.3× 135 0.7× 92 0.6× 242 1.8× 67 1.1k
Rick Popert United Kingdom 20 859 1.5× 277 0.9× 296 1.6× 170 1.2× 294 2.1× 77 1.4k
Tae Young Shin South Korea 19 667 1.2× 294 1.0× 181 1.0× 56 0.4× 133 1.0× 58 940
Claudia Collà Ruvolo Italy 18 496 0.9× 544 1.8× 110 0.6× 97 0.7× 233 1.7× 139 1.2k
David Eldred‐Evans United Kingdom 14 477 0.8× 139 0.5× 205 1.1× 162 1.1× 69 0.5× 40 689
Alessandro Morlacco Italy 17 505 0.9× 301 1.0× 202 1.1× 100 0.7× 172 1.2× 78 904
Nima Nassiri United States 16 377 0.7× 213 0.7× 151 0.8× 114 0.8× 54 0.4× 51 696
Stephan Hruby Austria 17 494 0.9× 227 0.8× 251 1.3× 83 0.6× 247 1.8× 60 800
Vinay Prabhu United States 19 395 0.7× 98 0.3× 110 0.6× 289 2.0× 101 0.7× 56 948
Adam W. Levinson United States 13 342 0.6× 173 0.6× 61 0.3× 83 0.6× 103 0.7× 28 584

Countries citing papers authored by Nathan Perlis

Since Specialization
Citations

This map shows the geographic impact of Nathan Perlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Perlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Perlis more than expected).

Fields of papers citing papers by Nathan Perlis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Perlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Perlis. The network helps show where Nathan Perlis may publish in the future.

Co-authorship network of co-authors of Nathan Perlis

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Perlis. A scholar is included among the top collaborators of Nathan Perlis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Perlis. Nathan Perlis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghai, Sangeet, Antonio Finelli, Katherine Lajkosz, et al.. (2024). MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial. Radiology. 310(3). e231473–e231473. 10 indexed citations
2.
Papadopoulos, Efthymios, et al.. (2024). Exploring the Language Used to Describe Older Patients at Multidisciplinary Cancer Conferences. Cancers. 16(8). 1477–1477.
3.
Mirshahvalad, Seyed Ali, Adriano Basso Dias, Sangeet Ghai, et al.. (2024). Value of Dynamic Contrast-Enhanced MRI for Grade Group Prediction in Prostate Cancer: A Radiomics Pilot Study. Academic Radiology. 32(1). 250–259.
4.
Basseri, Sana, Nathan Perlis, & Sangeet Ghai. (2024). Focal therapy for prostate cancer. Abdominal Radiology. 50(2). 757–769. 2 indexed citations
5.
Tan, Guan Hee, Dominik Deniffel, Antonio Finelli, et al.. (2023). Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance. Urologic Oncology Seminars and Original Investigations. 41(3). 146.e23–146.e28.
6.
Dias, Adriano Basso, Sangeet Ghai, Claudia Ortega, et al.. (2023). Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative Therapies. Clinical Nuclear Medicine. 48(10). e462–e467. 5 indexed citations
7.
Cheung, Douglas C., Karen E. Bremner, Reka Pataky, et al.. (2023). The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis. PLoS ONE. 18(9). e0290646–e0290646. 11 indexed citations
8.
Ghai, Sangeet, Nathan Perlis, Katherine Lajkosz, et al.. (2022). Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. Radiology. 305(2). 390–398. 22 indexed citations
9.
Perlis, Nathan, Antonio Finelli, Katherine Lajkosz, et al.. (2022). Exploring the value of using patient-oriented MRI reports in clinical practice — a pilot study. Supportive Care in Cancer. 30(8). 6857–6876. 1 indexed citations
10.
Cheung, Douglas C., Karen E. Bremner, Ruth Croxford, et al.. (2022). “Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs. Value in Health. 25(8). 1307–1316. 4 indexed citations
11.
Herrera‐Cáceres, Jaime O., Miran Kenk, Katherine Lajkosz, et al.. (2022). Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes. Urologic Oncology Seminars and Original Investigations. 40(7). 343.e1–343.e6. 2 indexed citations
12.
Ghai, Sangeet, Antonio Finelli, Rosanna Chan, et al.. (2021). MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. Radiology. 298(3). 695–703. 44 indexed citations
13.
Deniffel, Dominik, Gerard M. Healy, Xin Dong, et al.. (2021). Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer. Radiology. 300(2). 369–379. 52 indexed citations
14.
Herrera‐Cáceres, Jaime O., Katherine Lajkosz, Hanan Goldberg, et al.. (2020). Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes. European Urology Open Science. 21. 1–4. 1 indexed citations
15.
Perlis, Nathan, Sangeet Ghai, Guan Hee Tan, & Antonio Finelli. (2019). What are the limits of focal therapy for localized prostate cancer? For: GG3-5 may be considered. European Urology Focus. 6(2). 201–202. 3 indexed citations
16.
Sayyid, Rashid K., Shabbir M.H. Alibhai, Rinku Sutradhar, et al.. (2019). Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients. Urologic Oncology Seminars and Original Investigations. 37(5). 298.e19–298.e27. 10 indexed citations
17.
Ghai, Sangeet, Nathan Perlis, Uri Lindner, et al.. (2018). Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer – phase 1 trial. European Radiology. 28(10). 4281–4287. 33 indexed citations
18.
Sayyid, Rashid K., Dharmendra Dingar, Joshua M. Diamond, et al.. (2017). What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?. Canadian Urological Association Journal. 11(3-4). 118–118. 4 indexed citations
19.
Perlis, Nathan & Laurence Klotz. (2017). Contemporary Active Surveillance. Urologic Clinics of North America. 44(4). 565–574. 14 indexed citations
20.
Perlis, Nathan, Rashid K. Sayyid, Andrew Evans, et al.. (2016). Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance. The Journal of Urology. 197(1). 75–83. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026